View by Specialty

Trending

DERM1124DesaiQAGraphic01
November 11, 2024
6 min read
Save

Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access

Leukemia News

SPONSORED CONTENT
Save
SPONSORED CONTENT
August 16, 2024
1 min read
Save

Enrollment of trial assessing triplet for leukemia halted after ‘unexpected’ outcome

Enrollment of trial assessing triplet for leukemia halted after ‘unexpected’ outcome

Enrollment for a randomized phase 2 trial designed to compare a triplet regimen and doublet regimen for certain patients with leukemia has been discontinued due to low likelihood of benefit.

SPONSORED CONTENT
August 15, 2024
3 min read
Save

Spouses of people with cancer more likely to attempt, die of suicide

Spouses of people with cancer more likely to attempt, die of suicide

Spouses of people with cancer exhibited significantly higher risk for attempted suicide and suicide death than those whose spouses had not been diagnosed with cancer, according to a nationwide cohort study in Denmark.

Trending

DERM1124DesaiQAGraphic01
November 11, 2024
6 min read
Save

Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access

SPONSORED CONTENT
August 12, 2024
3 min read
Save

Tisagenlecleucel ‘can be curative’ for some children with acute leukemia

Tisagenlecleucel ‘can be curative’ for some children with acute leukemia

Children and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia increasingly receive tisagenlecleucel in earlier settings when they have lower disease burden, according to findings presented at ASCO Annual Meeting.

SPONSORED CONTENT
August 06, 2024
2 min read
Save

‘Quite striking’: Donor socioeconomic status may affect stem cell transplant outcomes

‘Quite striking’: Donor socioeconomic status may affect stem cell transplant outcomes

The socioeconomic status of cell donors may affect outcomes of people with blood cancer who undergo hematopoietic stem cell transplantation, according to retrospective study results.

SPONSORED CONTENT
July 31, 2024
1 min read
Save

European Medicines Agency recommends MabThera biosimilar for multiple indications

European Medicines Agency recommends MabThera biosimilar for multiple indications

The European Medicines Agency Committee for Medicinal Products for Human Use has recommended the launch of proposed biosimilar rituximab candidate Ituxredi, Dr. Reddy’s Laboratories announced in a press release.

SPONSORED CONTENT
July 29, 2024
1 min read
Save

Acalabrutinib regimens improve PFS vs. standard care in untreated CLL

Acalabrutinib regimens improve PFS vs. standard care in untreated CLL

Fixed-duration acalabrutinib plus venetoclax, with or without obinutuzumab, improved survival compared with standard chemoimmunotherapy for certain adults with leukemia, according to a topline data announcement.

SPONSORED CONTENT
July 25, 2024
1 min read
Save

Blinatumomab regimen improves survival for certain patients with acute leukemia

Blinatumomab regimen improves survival for certain patients with acute leukemia

Use of blinatumomab with consolidation chemotherapy significantly extended OS for adults with minimal residual disease-negative B-cell precursor acute lymphoblastic leukemia, according to randomized phase 3 study results.

SPONSORED CONTENT
July 19, 2024
2 min read
Save

Obe-cel improves EFS in advanced B-cell acute lymphoblastic leukemia

Obe-cel improves EFS in advanced B-cell acute lymphoblastic leukemia

Obecabtagene autoleucel conferred durable benefit to certain patients with relapsed or refractory B-cell acute lymphoblastic leukemia, according to results of the phase 1B/phase 2 FLEIX study presented at ASCO Annual Meeting.

SPONSORED CONTENT
July 18, 2024
3 min read
Save

Studies find benzoyl peroxide for acne has no increased risk for blood benzene, malignancy

Studies find benzoyl peroxide for acne has no increased risk for blood benzene, malignancy

Patients with acne who used benzoyl peroxide products did not have a risk for malignancy or increased blood benzene levels, according to a pair of studies published in the Journal of the American Academy of Dermatology.

SPONSORED CONTENT
July 16, 2024
2 min watch
Save

VIDEO: Asciminib results could yield ‘significant change’ in CML treatment

VIDEO: Asciminib results could yield ‘significant change’ in CML treatment

In this video, Eric Winer, MD, discusses the results of research into chronic myeloid leukemia presented at ASCO Annual Meeting.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails